METHOD FOR MANAGING HYPERGLYCEMIA IN A SUBJECT

Abstract

ABSTRACT A method (100) for managing hyperglycemia in a subject. Further, the method comprising administering an effective amount of Juglans regia extract to the subject. Further, the method (100) comprising the steps of obtaining the Juglans regia extract from at least one of the leaves, seeds, or oil of the Juglans regia plant. Further, the method (100) comprising the steps of determining the effective amount based on the subject's body weight and metabolic condition. Further, the method (100) comprising the steps of monitoring the subject's blood glucose levels before, during, and after the administration of the Juglans regia extract. Further, the method (100) comprising the steps of associating the hyperglycemia with diabetes mellitus type 2.

Specification

Description:FIELD OF THE DISCLOSURE
[0001] This invention generally relates to the field of dietary supplements and in particular relates to a method for utilizing Juglans regia extract as a natural agent for managing hyperglycemia in subjects with diabetes mellitus type 2, aimed at promoting health and wellness through the use of plant-derived compounds.
BACKGROUND
[0002] The subject matter discussed in the background section should not be assumed to be prior art merely as a result of its mention in the background section. Similarly, a problem mentioned in the background section or associated with the subject matter of the background section should not be assumed to have been previously recognized in the prior art. The subject matter in the background section merely represents different approaches, which in and of themselves may also correspond to implementations of the claimed technology.
[0003] Diabetes mellitus type 2 is a chronic metabolic disorder characterized by insulin resistance and elevated blood glucose le , Claims:1. A method (100) for managing hyperglycemia in a subject, the method comprising the steps of:
administering an effective amount of Juglans regia extract to the subject;
obtaining the Juglans regia extract from at least one of the leaves, seeds, or oil of the Juglans regia plant;
determining the effective amount based on the subject's body weight and metabolic condition;
monitoring the subject's blood glucose levels before, during, and after the administration of the Juglans regia extract;
associating the hyperglycemia with diabetes mellitus type 2.

2. The method (100) as claimed in claim 1, further comprising administering the Juglans regia extract in combination with a dietary regimen tailored to reduce blood glucose levels and evaluating the subject's response by measuring changes in hemoglobin A1c levels over a period of at least three months.

Documents